Oscar Health Announces Prelim. Q2 Results, Revises FY24 Revenue Outlook

Oscar Health (OSCR) announced preliminary second-quarter operating and net losses of approximately $230 million and $228 million, respectively. Concurrently, the company revised its full-year 2025 outlook, projecting total revenue between $12.0 billion and $12.2 billion, which surpasses average analyst estimates of $11.24 billion, alongside an anticipated adjusted EBITDA loss of around $120 million. This forward guidance appears to be positively received by investors, with OSCR shares trading up 1.73% in pre-market hours.

Analysis

Oscar Health (OSCR) has presented a mixed financial picture, reporting substantial preliminary second-quarter losses while simultaneously issuing bullish guidance for fiscal year 2025. The company anticipates a Q2 operating loss of approximately $230 million and a net loss of about $228 million, underscoring ongoing profitability challenges. However, the market appears to be forward-looking, as evidenced by the 1.73% pre-market stock increase. This positive reaction is directly tied to the revised 2025 outlook, which projects total revenue in the range of $12.0 billion to $12.2 billion. This forecast is significantly above the analyst consensus of $11.24 billion, signaling management's confidence in future growth. While the company still projects an adjusted EBITDA loss of approximately $120 million for 2025, the strong top-line guidance is the dominant driver of current investor sentiment.

Key Decisions for Investors

• Investors should recognize that the positive pre-market reaction is based on a forward-looking growth narrative, prioritizing the strong 2025 revenue forecast over significant near-term reported losses.
• Closely monitor future earnings reports for validation of the company's aggressive revenue trajectory, as any shortfall against the $12.0-$12.2 billion guidance could reverse current sentiment.
• Evaluate the company's progress toward its projected 2025 adjusted EBITDA loss of approximately $120 million, as this figure serves as a key benchmark for its path to eventual profitability.